+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Precision Medicine Market 2025-2029

  • PDF Icon

    Report

  • 222 Pages
  • June 2025
  • Region: Global
  • TechNavio
  • ID: 5821259
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The precision medicine market is forecasted to grow by USD 78.4 billion during 2024-2029, accelerating at a CAGR of 13% during the forecast period. The report on the precision medicine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of chronic diseases, increasing demand for personalized medicine, and advancements in genomics and proteomics.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

The precision medicine market is segmented as below:

By Application

  • Oncology
  • CNS
  • Respiratory
  • Immunology
  • Others

By Technology

  • Bioinformatics
  • Gene sequencing
  • Drug discovery
  • Precision molecular diagnostic
  • Big data analytics

By End-user

  • Pharmaceutical and biotechnology
  • Healthcare providers
  • Research and academic institutions
  • Diagnostic laboratories

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the growing use of artificial intelligence (AI) and machine learning (ML) in precision medicine as one of the prime reasons driving the precision medicine market growth during the next few years. Also, integration of genomics and digital health and rising recent developments in precision medicine will lead to sizable demand in the market.

The report on the precision medicine market covers the following areas:

  • Precision Medicine Market sizing
  • Precision Medicine Market forecast
  • Precision Medicine Market industry analysis
A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading precision medicine market vendors that include AbbVie Inc., Amgen Inc., AstraZeneca Plc, Biocrates Life Sciences AG, Bristol Myers Squibb Co., Catalent Inc., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., IQVIA Holdings Inc., Johnson and Johnson Services Inc., Lonza Group Ltd., Merck and Co. Inc., Novartis AG, Parexel International Corp., Pfizer Inc., QIAGEN N.V., Sanofi SA, Takeda Pharmaceutical Co. Ltd., and Thermo Fisher Scientific Inc. Also, the precision medicine market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Application
Executive Summary - Chart on Market Segmentation by Technology
Executive Summary - Chart on Market Segmentation by End-user
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Global - Market size and forecast 2024-2029 ($ billion)
Data Table on Global - Market size and forecast 2024-2029 ($ billion)
Chart on Global Market: Year-over-year growth 2024-2029 (%)
Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global Precision Medicine Market 2019 - 2023
Historic Market Size - Data Table on Global Precision Medicine Market 2019 - 2023 ($ billion)
5.2 Application segment analysis 2019 - 2023
Historic Market Size - Application Segment 2019 - 2023 ($ billion)
5.3 Technology segment analysis 2019 - 2023
Historic Market Size - Technology Segment 2019 - 2023 ($ billion)
5.4 End-user segment analysis 2019 - 2023
Historic Market Size - End-user Segment 2019 - 2023 ($ billion)
5.5 Geography segment analysis 2019 - 2023
Historic Market Size - Geography Segment 2019 - 2023 ($ billion)
5.6 Country segment analysis 2019 - 2023
Historic Market Size - Country Segment 2019 - 2023 ($ billion)
6 Qualitative Analysis
6.1 The impact of AI in the global precision medicine market
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Application
8.1 Market segments
Chart on Application - Market share 2024-2029 (%)
Data Table on Application - Market share 2024-2029 (%)
8.2 Comparison by Application
Chart on Comparison by Application
Data Table on Comparison by Application
8.3 Oncology - Market size and forecast 2024-2029
Chart on Oncology - Market size and forecast 2024-2029 ($ billion)
Data Table on Oncology - Market size and forecast 2024-2029 ($ billion)
Chart on Oncology - Year-over-year growth 2024-2029 (%)
Data Table on Oncology - Year-over-year growth 2024-2029 (%)
8.4 CNS - Market size and forecast 2024-2029
Chart on CNS - Market size and forecast 2024-2029 ($ billion)
Data Table on CNS - Market size and forecast 2024-2029 ($ billion)
Chart on CNS - Year-over-year growth 2024-2029 (%)
Data Table on CNS - Year-over-year growth 2024-2029 (%)
8.5 Respiratory - Market size and forecast 2024-2029
Chart on Respiratory - Market size and forecast 2024-2029 ($ billion)
Data Table on Respiratory - Market size and forecast 2024-2029 ($ billion)
Chart on Respiratory - Year-over-year growth 2024-2029 (%)
Data Table on Respiratory - Year-over-year growth 2024-2029 (%)
8.6 Immunology - Market size and forecast 2024-2029
Chart on Immunology - Market size and forecast 2024-2029 ($ billion)
Data Table on Immunology - Market size and forecast 2024-2029 ($ billion)
Chart on Immunology - Year-over-year growth 2024-2029 (%)
Data Table on Immunology - Year-over-year growth 2024-2029 (%)
8.7 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ billion)
Data Table on Others - Market size and forecast 2024-2029 ($ billion)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
8.8 Market opportunity by Application
Market opportunity by Application ($ billion)
Data Table on Market opportunity by Application ($ billion)
9 Market Segmentation by Technology
9.1 Market segments
Chart on Technology - Market share 2024-2029 (%)
Data Table on Technology - Market share 2024-2029 (%)
9.2 Comparison by Technology
Chart on Comparison by Technology
Data Table on Comparison by Technology
9.3 Bioinformatics - Market size and forecast 2024-2029
Chart on Bioinformatics - Market size and forecast 2024-2029 ($ billion)
Data Table on Bioinformatics - Market size and forecast 2024-2029 ($ billion)
Chart on Bioinformatics - Year-over-year growth 2024-2029 (%)
Data Table on Bioinformatics - Year-over-year growth 2024-2029 (%)
9.4 Gene sequencing - Market size and forecast 2024-2029
Chart on Gene sequencing - Market size and forecast 2024-2029 ($ billion)
Data Table on Gene sequencing - Market size and forecast 2024-2029 ($ billion)
Chart on Gene sequencing - Year-over-year growth 2024-2029 (%)
Data Table on Gene sequencing - Year-over-year growth 2024-2029 (%)
9.5 Drug discovery - Market size and forecast 2024-2029
Chart on Drug discovery - Market size and forecast 2024-2029 ($ billion)
Data Table on Drug discovery - Market size and forecast 2024-2029 ($ billion)
Chart on Drug discovery - Year-over-year growth 2024-2029 (%)
Data Table on Drug discovery - Year-over-year growth 2024-2029 (%)
9.6 Precision molecular diagnostic - Market size and forecast 2024-2029
Chart on Precision molecular diagnostic - Market size and forecast 2024-2029 ($ billion)
Data Table on Precision molecular diagnostic - Market size and forecast 2024-2029 ($ billion)
Chart on Precision molecular diagnostic - Year-over-year growth 2024-2029 (%)
Data Table on Precision molecular diagnostic - Year-over-year growth 2024-2029 (%)
9.7 Big data analytics - Market size and forecast 2024-2029
Chart on Big data analytics - Market size and forecast 2024-2029 ($ billion)
Data Table on Big data analytics - Market size and forecast 2024-2029 ($ billion)
Chart on Big data analytics - Year-over-year growth 2024-2029 (%)
Data Table on Big data analytics - Year-over-year growth 2024-2029 (%)
9.8 Market opportunity by Technology
Market opportunity by Technology ($ billion)
Data Table on Market opportunity by Technology ($ billion)
10 Market Segmentation by End-user
10.1 Market segments
Chart on End-user - Market share 2024-2029 (%)
Data Table on End-user - Market share 2024-2029 (%)
10.2 Comparison by End-user
Chart on Comparison by End-user
Data Table on Comparison by End-user
10.3 Pharmaceutical and biotechnology - Market size and forecast 2024-2029
Chart on Pharmaceutical and biotechnology - Market size and forecast 2024-2029 ($ billion)
Data Table on Pharmaceutical and biotechnology - Market size and forecast 2024-2029 ($ billion)
Chart on Pharmaceutical and biotechnology - Year-over-year growth 2024-2029 (%)
Data Table on Pharmaceutical and biotechnology - Year-over-year growth 2024-2029 (%)
10.4 Healthcare providers - Market size and forecast 2024-2029
Chart on Healthcare providers - Market size and forecast 2024-2029 ($ billion)
Data Table on Healthcare providers - Market size and forecast 2024-2029 ($ billion)
Chart on Healthcare providers - Year-over-year growth 2024-2029 (%)
Data Table on Healthcare providers - Year-over-year growth 2024-2029 (%)
10.5 Research and academic institutions - Market size and forecast 2024-2029
Chart on Research and academic institutions - Market size and forecast 2024-2029 ($ billion)
Data Table on Research and academic institutions - Market size and forecast 2024-2029 ($ billion)
Chart on Research and academic institutions - Year-over-year growth 2024-2029 (%)
Data Table on Research and academic institutions - Year-over-year growth 2024-2029 (%)
10.6 Diagnostic laboratories - Market size and forecast 2024-2029
Chart on Diagnostic laboratories - Market size and forecast 2024-2029 ($ billion)
Data Table on Diagnostic laboratories - Market size and forecast 2024-2029 ($ billion)
Chart on Diagnostic laboratories - Year-over-year growth 2024-2029 (%)
Data Table on Diagnostic laboratories - Year-over-year growth 2024-2029 (%)
10.7 Market opportunity by End-user
Market opportunity by End-user ($ billion)
Data Table on Market opportunity by End-user ($ billion)
11 Customer Landscape
11.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2024-2029 (%)
Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
Chart on North America - Market size and forecast 2024-2029 ($ billion)
Data Table on North America - Market size and forecast 2024-2029 ($ billion)
Chart on North America - Year-over-year growth 2024-2029 (%)
Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
Chart on Europe - Market size and forecast 2024-2029 ($ billion)
Data Table on Europe - Market size and forecast 2024-2029 ($ billion)
Chart on Europe - Year-over-year growth 2024-2029 (%)
Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
Chart on Asia - Market size and forecast 2024-2029 ($ billion)
Data Table on Asia - Market size and forecast 2024-2029 ($ billion)
Chart on Asia - Year-over-year growth 2024-2029 (%)
Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
Chart on US - Market size and forecast 2024-2029 ($ billion)
Data Table on US - Market size and forecast 2024-2029 ($ billion)
Chart on US - Year-over-year growth 2024-2029 (%)
Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 Germany - Market size and forecast 2024-2029
Chart on Germany - Market size and forecast 2024-2029 ($ billion)
Data Table on Germany - Market size and forecast 2024-2029 ($ billion)
Chart on Germany - Year-over-year growth 2024-2029 (%)
Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.9 Canada - Market size and forecast 2024-2029
Chart on Canada - Market size and forecast 2024-2029 ($ billion)
Data Table on Canada - Market size and forecast 2024-2029 ($ billion)
Chart on Canada - Year-over-year growth 2024-2029 (%)
Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.10 China - Market size and forecast 2024-2029
Chart on China - Market size and forecast 2024-2029 ($ billion)
Data Table on China - Market size and forecast 2024-2029 ($ billion)
Chart on China - Year-over-year growth 2024-2029 (%)
Data Table on China - Year-over-year growth 2024-2029 (%)
12.11 UK - Market size and forecast 2024-2029
Chart on UK - Market size and forecast 2024-2029 ($ billion)
Data Table on UK - Market size and forecast 2024-2029 ($ billion)
Chart on UK - Year-over-year growth 2024-2029 (%)
Data Table on UK - Year-over-year growth 2024-2029 (%)
12.12 Japan - Market size and forecast 2024-2029
Chart on Japan - Market size and forecast 2024-2029 ($ billion)
Data Table on Japan - Market size and forecast 2024-2029 ($ billion)
Chart on Japan - Year-over-year growth 2024-2029 (%)
Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.13 France - Market size and forecast 2024-2029
Chart on France - Market size and forecast 2024-2029 ($ billion)
Data Table on France - Market size and forecast 2024-2029 ($ billion)
Chart on France - Year-over-year growth 2024-2029 (%)
Data Table on France - Year-over-year growth 2024-2029 (%)
12.14 India - Market size and forecast 2024-2029
Chart on India - Market size and forecast 2024-2029 ($ billion)
Data Table on India - Market size and forecast 2024-2029 ($ billion)
Chart on India - Year-over-year growth 2024-2029 (%)
Data Table on India - Year-over-year growth 2024-2029 (%)
12.15 Italy - Market size and forecast 2024-2029
Chart on Italy - Market size and forecast 2024-2029 ($ billion)
Data Table on Italy - Market size and forecast 2024-2029 ($ billion)
Chart on Italy - Year-over-year growth 2024-2029 (%)
Data Table on Italy - Year-over-year growth 2024-2029 (%)
12.16 Brazil - Market size and forecast 2024-2029
Chart on Brazil - Market size and forecast 2024-2029 ($ billion)
Data Table on Brazil - Market size and forecast 2024-2029 ($ billion)
Chart on Brazil - Year-over-year growth 2024-2029 (%)
Data Table on Brazil - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ billion)
Data Tables on Market opportunity By Geographical Landscape ($ billion)
13 Drivers, Challenges, and Opportunity/Restraints
13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
Overview on factors of disruption
14.4 Industry risks
Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
Companies covered
15.2 Company ranking index
Company ranking index
15.3 Market positioning of companies
Matrix on companies position and classification
15.4 Amgen Inc.
Amgen Inc. - Overview
Amgen Inc. - Product/Service
Amgen Inc. - Key news
Amgen Inc. - Key offerings
SWOT
15.5 AstraZeneca Plc
AstraZeneca Plc - Overview
AstraZeneca Plc - Product/Service
AstraZeneca Plc - Key news
AstraZeneca Plc - Key offerings
SWOT
15.6 Bristol Myers Squibb Co.
Bristol Myers Squibb Co. - Overview
Bristol Myers Squibb Co. - Product/Service
Bristol Myers Squibb Co. - Key news
Bristol Myers Squibb Co. - Key offerings
SWOT
15.7 Catalent Inc.
Catalent Inc. - Overview
Catalent Inc. - Business segments
Catalent Inc. - Key offerings
Catalent Inc. - Segment focus
SWOT
15.8 Eli Lilly and Co.
Eli Lilly and Co. - Overview
Eli Lilly and Co. - Product/Service
Eli Lilly and Co. - Key offerings
SWOT
15.9 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
SWOT
15.10 Gilead Sciences Inc.
Gilead Sciences Inc. - Overview
Gilead Sciences Inc. - Product/Service
Gilead Sciences Inc. - Key news
Gilead Sciences Inc. - Key offerings
SWOT
15.11 Johnson and Johnson Services Inc.
Johnson and Johnson Services Inc. - Overview
Johnson and Johnson Services Inc. - Business segments
Johnson and Johnson Services Inc. - Key news
Johnson and Johnson Services Inc. - Key offerings
Johnson and Johnson Services Inc. - Segment focus
SWOT
15.12 Lonza Group Ltd.
Lonza Group Ltd. - Overview
Lonza Group Ltd. - Business segments
Lonza Group Ltd. - Key news
Lonza Group Ltd. - Key offerings
Lonza Group Ltd. - Segment focus
SWOT
15.13 Merck and Co. Inc.
Merck and Co. Inc. - Overview
Merck and Co. Inc. - Business segments
Merck and Co. Inc. - Key news
Merck and Co. Inc. - Key offerings
Merck and Co. Inc. - Segment focus
SWOT
15.14 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
SWOT
15.15 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product/Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
SWOT
15.16 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus
SWOT
15.17 Takeda Pharmaceutical Co. Ltd.
Takeda Pharmaceutical Co. Ltd. - Overview
Takeda Pharmaceutical Co. Ltd. - Product/Service
Takeda Pharmaceutical Co. Ltd. - Key news
Takeda Pharmaceutical Co. Ltd. - Key offerings
SWOT
15.18 Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. - Overview
Thermo Fisher Scientific Inc. - Business segments
Thermo Fisher Scientific Inc. - Key news
Thermo Fisher Scientific Inc. - Key offerings
Thermo Fisher Scientific Inc. - Segment focus
SWOT
16 Appendix
16.1 Scope of the report
16.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
16.3 Currency conversion rates for US$
Currency conversion rates for US$
16.4 Research methodology
Research methodology
16.5 Data procurement
Information sources
16.6 Data validation
Data validation
16.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
16.8 Data synthesis
Data synthesis
16.9 360 degree market analysis
360 degree market analysis
16.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Application
Exhibits 6: Executive Summary - Chart on Market Segmentation by Technology
Exhibits 7: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 8: Executive Summary - Chart on Incremental Growth
Exhibits 9: Executive Summary - Data Table on Incremental Growth
Exhibits 10: Executive Summary - Chart on Company Market Positioning
Exhibits 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 12: Overview on criticality of inputs and factors of differentiation
Exhibits 13: Overview on factors of disruption
Exhibits 14: Impact of drivers and challenges in 2024 and 2029
Exhibits 15: Parent Market
Exhibits 16: Data Table on - Parent Market
Exhibits 17: Market characteristics analysis
Exhibits 18: Value chain analysis
Exhibits 19: Offerings of companies included in the market definition
Exhibits 20: Market segments
Exhibits 21: Chart on Global - Market size and forecast 2024-2029 ($ billion)
Exhibits 22: Data Table on Global - Market size and forecast 2024-2029 ($ billion)
Exhibits 23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 25: Historic Market Size - Data Table on Global Precision Medicine Market 2019 - 2023 ($ billion)
Exhibits 26: Historic Market Size - Application Segment 2019 - 2023 ($ billion)
Exhibits 27: Historic Market Size - Technology Segment 2019 - 2023 ($ billion)
Exhibits 28: Historic Market Size - End-user Segment 2019 - 2023 ($ billion)
Exhibits 29: Historic Market Size - Geography Segment 2019 - 2023 ($ billion)
Exhibits 30: Historic Market Size - Country Segment 2019 - 2023 ($ billion)
Exhibits 31: Five forces analysis - Comparison between 2024 and 2029
Exhibits 32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits 33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits 34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits 35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits 36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits 37: Chart on Market condition - Five forces 2024 and 2029
Exhibits 38: Chart on Application - Market share 2024-2029 (%)
Exhibits 39: Data Table on Application - Market share 2024-2029 (%)
Exhibits 40: Chart on Comparison by Application
Exhibits 41: Data Table on Comparison by Application
Exhibits 42: Chart on Oncology - Market size and forecast 2024-2029 ($ billion)
Exhibits 43: Data Table on Oncology - Market size and forecast 2024-2029 ($ billion)
Exhibits 44: Chart on Oncology - Year-over-year growth 2024-2029 (%)
Exhibits 45: Data Table on Oncology - Year-over-year growth 2024-2029 (%)
Exhibits 46: Chart on CNS - Market size and forecast 2024-2029 ($ billion)
Exhibits 47: Data Table on CNS - Market size and forecast 2024-2029 ($ billion)
Exhibits 48: Chart on CNS - Year-over-year growth 2024-2029 (%)
Exhibits 49: Data Table on CNS - Year-over-year growth 2024-2029 (%)
Exhibits 50: Chart on Respiratory - Market size and forecast 2024-2029 ($ billion)
Exhibits 51: Data Table on Respiratory - Market size and forecast 2024-2029 ($ billion)
Exhibits 52: Chart on Respiratory - Year-over-year growth 2024-2029 (%)
Exhibits 53: Data Table on Respiratory - Year-over-year growth 2024-2029 (%)
Exhibits 54: Chart on Immunology - Market size and forecast 2024-2029 ($ billion)
Exhibits 55: Data Table on Immunology - Market size and forecast 2024-2029 ($ billion)
Exhibits 56: Chart on Immunology - Year-over-year growth 2024-2029 (%)
Exhibits 57: Data Table on Immunology - Year-over-year growth 2024-2029 (%)
Exhibits 58: Chart on Others - Market size and forecast 2024-2029 ($ billion)
Exhibits 59: Data Table on Others - Market size and forecast 2024-2029 ($ billion)
Exhibits 60: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits 61: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits 62: Market opportunity by Application ($ billion)
Exhibits 63: Data Table on Market opportunity by Application ($ billion)
Exhibits 64: Chart on Technology - Market share 2024-2029 (%)
Exhibits 65: Data Table on Technology - Market share 2024-2029 (%)
Exhibits 66: Chart on Comparison by Technology
Exhibits 67: Data Table on Comparison by Technology
Exhibits 68: Chart on Bioinformatics - Market size and forecast 2024-2029 ($ billion)
Exhibits 69: Data Table on Bioinformatics - Market size and forecast 2024-2029 ($ billion)
Exhibits 70: Chart on Bioinformatics - Year-over-year growth 2024-2029 (%)
Exhibits 71: Data Table on Bioinformatics - Year-over-year growth 2024-2029 (%)
Exhibits 72: Chart on Gene sequencing - Market size and forecast 2024-2029 ($ billion)
Exhibits 73: Data Table on Gene sequencing - Market size and forecast 2024-2029 ($ billion)
Exhibits 74: Chart on Gene sequencing - Year-over-year growth 2024-2029 (%)
Exhibits 75: Data Table on Gene sequencing - Year-over-year growth 2024-2029 (%)
Exhibits 76: Chart on Drug discovery - Market size and forecast 2024-2029 ($ billion)
Exhibits 77: Data Table on Drug discovery - Market size and forecast 2024-2029 ($ billion)
Exhibits 78: Chart on Drug discovery - Year-over-year growth 2024-2029 (%)
Exhibits 79: Data Table on Drug discovery - Year-over-year growth 2024-2029 (%)
Exhibits 80: Chart on Precision molecular diagnostic - Market size and forecast 2024-2029 ($ billion)
Exhibits 81: Data Table on Precision molecular diagnostic - Market size and forecast 2024-2029 ($ billion)
Exhibits 82: Chart on Precision molecular diagnostic - Year-over-year growth 2024-2029 (%)
Exhibits 83: Data Table on Precision molecular diagnostic - Year-over-year growth 2024-2029 (%)
Exhibits 84: Chart on Big data analytics - Market size and forecast 2024-2029 ($ billion)
Exhibits 85: Data Table on Big data analytics - Market size and forecast 2024-2029 ($ billion)
Exhibits 86: Chart on Big data analytics - Year-over-year growth 2024-2029 (%)
Exhibits 87: Data Table on Big data analytics - Year-over-year growth 2024-2029 (%)
Exhibits 88: Market opportunity by Technology ($ billion)
Exhibits 89: Data Table on Market opportunity by Technology ($ billion)
Exhibits 90: Chart on End-user - Market share 2024-2029 (%)
Exhibits 91: Data Table on End-user - Market share 2024-2029 (%)
Exhibits 92: Chart on Comparison by End-user
Exhibits 93: Data Table on Comparison by End-user
Exhibits 94: Chart on Pharmaceutical and biotechnology - Market size and forecast 2024-2029 ($ billion)
Exhibits 95: Data Table on Pharmaceutical and biotechnology - Market size and forecast 2024-2029 ($ billion)
Exhibits 96: Chart on Pharmaceutical and biotechnology - Year-over-year growth 2024-2029 (%)
Exhibits 97: Data Table on Pharmaceutical and biotechnology - Year-over-year growth 2024-2029 (%)
Exhibits 98: Chart on Healthcare providers - Market size and forecast 2024-2029 ($ billion)
Exhibits 99: Data Table on Healthcare providers - Market size and forecast 2024-2029 ($ billion)
Exhibits 100: Chart on Healthcare providers - Year-over-year growth 2024-2029 (%)
Exhibits 101: Data Table on Healthcare providers - Year-over-year growth 2024-2029 (%)
Exhibits 102: Chart on Research and academic institutions - Market size and forecast 2024-2029 ($ billion)
Exhibits 103: Data Table on Research and academic institutions - Market size and forecast 2024-2029 ($ billion)
Exhibits 104: Chart on Research and academic institutions - Year-over-year growth 2024-2029 (%)
Exhibits 105: Data Table on Research and academic institutions - Year-over-year growth 2024-2029 (%)
Exhibits 106: Chart on Diagnostic laboratories - Market size and forecast 2024-2029 ($ billion)
Exhibits 107: Data Table on Diagnostic laboratories - Market size and forecast 2024-2029 ($ billion)
Exhibits 108: Chart on Diagnostic laboratories - Year-over-year growth 2024-2029 (%)
Exhibits 109: Data Table on Diagnostic laboratories - Year-over-year growth 2024-2029 (%)
Exhibits 110: Market opportunity by End-user ($ billion)
Exhibits 111: Data Table on Market opportunity by End-user ($ billion)
Exhibits 112: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 113: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 114: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 115: Chart on Geographic comparison
Exhibits 116: Data Table on Geographic comparison
Exhibits 117: Chart on North America - Market size and forecast 2024-2029 ($ billion)
Exhibits 118: Data Table on North America - Market size and forecast 2024-2029 ($ billion)
Exhibits 119: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits 120: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits 121: Chart on Europe - Market size and forecast 2024-2029 ($ billion)
Exhibits 122: Data Table on Europe - Market size and forecast 2024-2029 ($ billion)
Exhibits 123: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 124: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 125: Chart on Asia - Market size and forecast 2024-2029 ($ billion)
Exhibits 126: Data Table on Asia - Market size and forecast 2024-2029 ($ billion)
Exhibits 127: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 128: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 129: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
Exhibits 130: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
Exhibits 131: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 132: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 133: Chart on US - Market size and forecast 2024-2029 ($ billion)
Exhibits 134: Data Table on US - Market size and forecast 2024-2029 ($ billion)
Exhibits 135: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits 136: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits 137: Chart on Germany - Market size and forecast 2024-2029 ($ billion)
Exhibits 138: Data Table on Germany - Market size and forecast 2024-2029 ($ billion)
Exhibits 139: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 140: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 141: Chart on Canada - Market size and forecast 2024-2029 ($ billion)
Exhibits 142: Data Table on Canada - Market size and forecast 2024-2029 ($ billion)
Exhibits 143: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 144: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 145: Chart on China - Market size and forecast 2024-2029 ($ billion)
Exhibits 146: Data Table on China - Market size and forecast 2024-2029 ($ billion)
Exhibits 147: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits 148: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits 149: Chart on UK - Market size and forecast 2024-2029 ($ billion)
Exhibits 150: Data Table on UK - Market size and forecast 2024-2029 ($ billion)
Exhibits 151: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits 152: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits 153: Chart on Japan - Market size and forecast 2024-2029 ($ billion)
Exhibits 154: Data Table on Japan - Market size and forecast 2024-2029 ($ billion)
Exhibits 155: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 156: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 157: Chart on France - Market size and forecast 2024-2029 ($ billion)
Exhibits 158: Data Table on France - Market size and forecast 2024-2029 ($ billion)
Exhibits 159: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits 160: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits 161: Chart on India - Market size and forecast 2024-2029 ($ billion)
Exhibits 162: Data Table on India - Market size and forecast 2024-2029 ($ billion)
Exhibits 163: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits 164: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits 165: Chart on Italy - Market size and forecast 2024-2029 ($ billion)
Exhibits 166: Data Table on Italy - Market size and forecast 2024-2029 ($ billion)
Exhibits 167: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibits 168: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibits 169: Chart on Brazil - Market size and forecast 2024-2029 ($ billion)
Exhibits 170: Data Table on Brazil - Market size and forecast 2024-2029 ($ billion)
Exhibits 171: Chart on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits 172: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits 173: Market opportunity By Geographical Landscape ($ billion)
Exhibits 174: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits 175: Impact of drivers and challenges in 2024 and 2029
Exhibits 176: Overview on criticality of inputs and factors of differentiation
Exhibits 177: Overview on factors of disruption
Exhibits 178: Impact of key risks on business
Exhibits 179: Companies covered
Exhibits 180: Company ranking index
Exhibits 181: Matrix on companies position and classification
Exhibits 182: Amgen Inc. - Overview
Exhibits 183: Amgen Inc. - Product / Service
Exhibits 184: Amgen Inc. - Key news
Exhibits 185: Amgen Inc. - Key offerings
Exhibits 186: SWOT
Exhibits 187: AstraZeneca Plc - Overview
Exhibits 188: AstraZeneca Plc - Product / Service
Exhibits 189: AstraZeneca Plc - Key news
Exhibits 190: AstraZeneca Plc - Key offerings
Exhibits 191: SWOT
Exhibits 192: Bristol Myers Squibb Co. - Overview
Exhibits 193: Bristol Myers Squibb Co. - Product / Service
Exhibits 194: Bristol Myers Squibb Co. - Key news
Exhibits 195: Bristol Myers Squibb Co. - Key offerings
Exhibits 196: SWOT
Exhibits 197: Catalent Inc. - Overview
Exhibits 198: Catalent Inc. - Business segments
Exhibits 199: Catalent Inc. - Key offerings
Exhibits 200: Catalent Inc. - Segment focus
Exhibits 201: SWOT
Exhibits 202: Eli Lilly and Co. - Overview
Exhibits 203: Eli Lilly and Co. - Product / Service
Exhibits 204: Eli Lilly and Co. - Key offerings
Exhibits 205: SWOT
Exhibits 206: F. Hoffmann La Roche Ltd. - Overview
Exhibits 207: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 208: F. Hoffmann La Roche Ltd. - Key news
Exhibits 209: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 210: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 211: SWOT
Exhibits 212: Gilead Sciences Inc. - Overview
Exhibits 213: Gilead Sciences Inc. - Product / Service
Exhibits 214: Gilead Sciences Inc. - Key news
Exhibits 215: Gilead Sciences Inc. - Key offerings
Exhibits 216: SWOT
Exhibits 217: Johnson and Johnson Services Inc. - Overview
Exhibits 218: Johnson and Johnson Services Inc. - Business segments
Exhibits 219: Johnson and Johnson Services Inc. - Key news
Exhibits 220: Johnson and Johnson Services Inc. - Key offerings
Exhibits 221: Johnson and Johnson Services Inc. - Segment focus
Exhibits 222: SWOT
Exhibits 223: Lonza Group Ltd. - Overview
Exhibits 224: Lonza Group Ltd. - Business segments
Exhibits 225: Lonza Group Ltd. - Key news
Exhibits 226: Lonza Group Ltd. - Key offerings
Exhibits 227: Lonza Group Ltd. - Segment focus
Exhibits 228: SWOT
Exhibits 229: Merck and Co. Inc. - Overview
Exhibits 230: Merck and Co. Inc. - Business segments
Exhibits 231: Merck and Co. Inc. - Key news
Exhibits 232: Merck and Co. Inc. - Key offerings
Exhibits 233: Merck and Co. Inc. - Segment focus
Exhibits 234: SWOT
Exhibits 235: Novartis AG - Overview
Exhibits 236: Novartis AG - Business segments
Exhibits 237: Novartis AG - Key news
Exhibits 238: Novartis AG - Key offerings
Exhibits 239: Novartis AG - Segment focus
Exhibits 240: SWOT
Exhibits 241: Pfizer Inc. - Overview
Exhibits 242: Pfizer Inc. - Product / Service
Exhibits 243: Pfizer Inc. - Key news
Exhibits 244: Pfizer Inc. - Key offerings
Exhibits 245: SWOT
Exhibits 246: Sanofi SA - Overview
Exhibits 247: Sanofi SA - Business segments
Exhibits 248: Sanofi SA - Key news
Exhibits 249: Sanofi SA - Key offerings
Exhibits 250: Sanofi SA - Segment focus
Exhibits 251: SWOT
Exhibits 252: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits 253: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits 254: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits 255: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits 256: SWOT
Exhibits 257: Thermo Fisher Scientific Inc. - Overview
Exhibits 258: Thermo Fisher Scientific Inc. - Business segments
Exhibits 259: Thermo Fisher Scientific Inc. - Key news
Exhibits 260: Thermo Fisher Scientific Inc. - Key offerings
Exhibits 261: Thermo Fisher Scientific Inc. - Segment focus
Exhibits 262: SWOT
Exhibits 263: Inclusions checklist
Exhibits 264: Exclusions checklist
Exhibits 265: Currency conversion rates for US$
Exhibits 266: Research methodology
Exhibits 267: Information sources
Exhibits 268: Data validation
Exhibits 269: Validation techniques employed for market sizing
Exhibits 270: Data synthesis
Exhibits 271: 360 degree market analysis
Exhibits 272: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global precision medicine market: AbbVie Inc., Amgen Inc., AstraZeneca Plc, Biocrates Life Sciences AG, Bristol Myers Squibb Co., Catalent Inc., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., IQVIA Holdings Inc., Johnson and Johnson Services Inc., Lonza Group Ltd., Merck and Co. Inc., Novartis AG, Parexel International Corp., Pfizer Inc., QIAGEN N.V., Sanofi SA, Takeda Pharmaceutical Co. Ltd., and Thermo Fisher Scientific Inc..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is growing use of artificial intelligence (AI) and machine learning (ML) in precision medicine."

According to the report, one of the major drivers for this market is the growing prevalence of chronic diseases.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca Plc
  • Biocrates Life Sciences AG
  • Bristol Myers Squibb Co.
  • Catalent Inc.
  • Eli Lilly and Co.
  • F. Hoffmann La Roche Ltd.
  • Gilead Sciences Inc.
  • IQVIA Holdings Inc.
  • Johnson and Johnson Services Inc.
  • Lonza Group Ltd.
  • Merck and Co. Inc.
  • Novartis AG
  • Parexel International Corp.
  • Pfizer Inc.
  • QIAGEN N.V.
  • Sanofi SA
  • Takeda Pharmaceutical Co. Ltd.
  • Thermo Fisher Scientific Inc.